This study analysed recently available data on the HoR and HER2 status in metastatic breast cancer patients from the SEER registries, in an attempt to identify differences in the influence of the breast cancer subtype on the patient prognosis, site of distant metastasis and the effect of primary tumour surgery. The gene discussed is ERBB2; the disease is neoplasm.